Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Influenza, Human, Date of authorisation: 20/05/2016, Revision: 3, Status: Authorised
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.